What happened
Fuying (Shanghai) Medical Technology built AIneurysm, deep learning software that marks suspected saccular aneurysms of 3 mm or more on brain MR angiograms. The Paper reports that a Fudan University team led its development. The Center for Medical Device Evaluation (CMDE) of China's National Medical Products Administration reviewed the application for Class III registration. The trial was the maker's own, a retrospective, fully crossed multi-reader study of 484 analyzed cases from three centers. Each doctor read every case alone and with the software, at least four weeks apart. With the software, lesion-level sensitivity rose by 0.0698 (95% CI 0.0358 to 0.1037). Specificity met the non-inferiority margin. Median reading time was 2.02 minutes with the software and 1.47 minutes without. On 13 August 2024, CMDE concluded that “该产品上市带来的受益大于风险” (putting the product on the market brings benefits that outweigh the risks). It recommended approval. The doctors read stored images, so the software guided no care. The Fudan team told The Paper that the software cut reading time per case by 60%. The review report shows longer reading with the software.
Sources
-
Regulatory document, by authors with no tie to the system.
病灶水平下 AI 辅助阅片与单独阅片对动脉瘤检出灵敏度差值的 95%置信区间下限大于优效界值
综上,该产品上市带来的受益大于风险,综合剩余风险可接受。
-
News report, by authors with no tie to the system. Context or contrary evidence.
The Paper (澎湃新闻), republished by ifeng.com (凤凰网科技). 高校主导、临床医生牵头,这款软件获批三类医疗器械注册证 (Led by a university and clinicians, this software wins a Class III medical device registration certificate). 6 September 2024. The figures are the development team's statements to the reporter.
颅内动脉瘤磁共振造影图像辅助检测软件提升动脉瘤检出率10%,诊断效能由82%提高到94%,每例阅片时间缩短60%
Details
AI system
- Reported configuration
-
Release 1 (full version 1.0.0.20240116)
- Workflow
-
The software extracted the intracranial arteries from MR angiograms and marked suspected saccular aneurysms with deep learning. Doctors could edit the marks and produce a text report.
Follow-up
- Conditions for replication
-
Images are brain MR angiograms, and aneurysms are 3 mm or larger. Trained doctors read the images and do not base a clinical decision on the software alone.
Entry details
- Sector
-
Healthcare.
- Purpose
-
Fuying (Shanghai) Medical Technology built AIneurysm to help trained doctors detect intracranial saccular aneurysms of 3 mm or more on brain MR angiography images.
29 more questions not yet checked
model, provider, role, configuration, inputs and outputs, autonomy, human oversight, beneficiaries, reach, distribution and access, duration, every measurement question, every money question, ownership and control, dependencies, cross-border connections, geopolitical implications, replication attempts, availability, institutional decision, grounds, action and result, success criterion, every evidence question, observed or intended, alternative assessments, related entries, other identifiers, category mappings.
Cite this record
Peter H. Vartanian. (2026). AIneurysm helped doctors find more brain aneurysms on MR scans (AIBD-1061). Artificial Intelligence Benefits Database, edition of 1 November 2026. https://petervartanian.xyz/aibd/records/AIBD-1061.html (archived at https://doi.org/10.7910/DVN/AADSII, version 7.0)